Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18216)

• Formulation Name: Propylthiouracil 50 mg tablet
• Company: DAVA Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Propylthiouracil	(DM6D7N8)	Hyperthyroidism	5A02	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Docusate sodium	(E00563)	23673837	Surfactant
Magnesium stearate	(E00208)	11177	lubricant
Sodium benzoate	(E00432)	517055	Antimicrobial preservative; lubricant